Search research articles
Contact Us
Filters
Showing results (11-20 of 350) with videos related to
Page
of 35
Sort By:
Frontiers in Pharmacology
|
October 18, 2018
Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
Anita Balázs, Marcus A Mall
The European Respiratory Journal
|
June 14, 2014
CFTR: cystic fibrosis and beyond
Marcus A Mall, Dominik Hartl
Molecular and Cellular Pediatrics
|
June 5, 2024
Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
Tilmann Kallinich, Marcus A Mall
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 4, 2026
Predicting pulmonary exacerbations in cystic fibrosis subpopulations and implications for clinical trial design
Stephanie Thee, Marcus A Mall
The European Respiratory Journal
|
October 10, 2024
How many functioning ciliated airway epithelial cells are necessary for effective mucociliary clearance?
Ruth M Urbantat, Marcus A Mall
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 3, 2014
Chronic ivacaftor treatment: getting F508del-CFTR into more trouble?
Marcus A Mall, David N Sheppard
Lancet (London, England)
|
September 12, 2023
The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches
Simon Y Graeber, Marcus A Mall
The European Respiratory Journal
|
March 28, 2024
Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis
Mark O Wielpütz, Marcus A Mall
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 24, 2016
MRI accelerating progress in functional assessment of cystic fibrosis lung disease
Mark O Wielpütz, Marcus A Mall
Current Opinion in Pulmonary Medicine
|
September 22, 2015
Imaging modalities in cystic fibrosis: emerging role of MRI
Mark O Wielpütz, Marcus A Mall
Page
of 35
Search research articles
Search
Showing results (11-20 of 350) with videos related to
Sort By:
Page
of 35
Frontiers in Pharmacology
|
October 18, 2018
Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
Anita Balázs, Marcus A Mall
The European Respiratory Journal
|
June 14, 2014
CFTR: cystic fibrosis and beyond
Marcus A Mall, Dominik Hartl
Molecular and Cellular Pediatrics
|
June 5, 2024
Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
Tilmann Kallinich, Marcus A Mall
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 4, 2026
Predicting pulmonary exacerbations in cystic fibrosis subpopulations and implications for clinical trial design
Stephanie Thee, Marcus A Mall
The European Respiratory Journal
|
October 10, 2024
How many functioning ciliated airway epithelial cells are necessary for effective mucociliary clearance?
Ruth M Urbantat, Marcus A Mall
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 3, 2014
Chronic ivacaftor treatment: getting F508del-CFTR into more trouble?
Marcus A Mall, David N Sheppard
Lancet (London, England)
|
September 12, 2023
The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches
Simon Y Graeber, Marcus A Mall
The European Respiratory Journal
|
March 28, 2024
Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis
Mark O Wielpütz, Marcus A Mall
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 24, 2016
MRI accelerating progress in functional assessment of cystic fibrosis lung disease
Mark O Wielpütz, Marcus A Mall
Current Opinion in Pulmonary Medicine
|
September 22, 2015
Imaging modalities in cystic fibrosis: emerging role of MRI
Mark O Wielpütz, Marcus A Mall
Page
of 35